Search company, investor...
Nivien Therapeutics company logo

Nivien Therapeutics

Founded Year



Convertible Note | Alive

About Nivien Therapeutics

Nivien Therapeutics identifies and develops undervalued discoveries in the life sciences. The company's flagship program is an oncology platform. Nivien is a new platform to enhance IO-chemo combo therapies for treatment-resistant cancers by targeting the Hippo-YAP pathway.

Headquarters Location

125 Western Avenue

Boston, Massachusetts, 02163,

United States

Missing: Nivien Therapeutics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Nivien Therapeutics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Nivien Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Nivien Therapeutics is included in 1 Expert Collection, including Cancer.



4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

Nivien Therapeutics Patents

Nivien Therapeutics has filed 1 patent.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Human proteins
  • Immunology
patents chart

Application Date

Grant Date


Related Topics



Transcription factors, Human proteins, Proteins, Clusters of differentiation, Immunology


Application Date


Grant Date


Related Topics

Transcription factors, Human proteins, Proteins, Clusters of differentiation, Immunology



Nivien Therapeutics Frequently Asked Questions (FAQ)

  • When was Nivien Therapeutics founded?

    Nivien Therapeutics was founded in 2017.

  • Where is Nivien Therapeutics's headquarters?

    Nivien Therapeutics's headquarters is located at 125 Western Avenue, Boston.

  • What is Nivien Therapeutics's latest funding round?

    Nivien Therapeutics's latest funding round is Convertible Note.

  • Who are the investors of Nivien Therapeutics?

    Investors of Nivien Therapeutics include IndieBio, SOSV, Harvard Venture Incubation Program and MassChallenge.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.